Has Jessin John received payments from drug or device companies?

Yes. Drug and device makers reported $8,150 in general payments to Jessin John across 92 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jessin John did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jessin John come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jessin John

Interventional Pain Medicine · New Orleans, LANPI 1184042806

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,396 of the $8,150 with a category attached, or 78.5%. 15 manufacturers reported payments, led by Boston Scientific at 47.6% of the total. Reporting peaked in 2024 at $3,341 and has fallen 73.5% since, to $886 in 2025.

$8,150in general payments, 2019–2025

Across 92 payments — averaging $88.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$4K
Medtronic$1K
Nevro Corp.$708
Abbott$652
Averitas Pharma Inc.$505
Saluda Medical Americas, Inc.$367
plus $1K from 9 others

What the payments were for

Travel & lodging$1,75422%
Food & beverage$6,39678%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	38	$3,875
Medtronic	14	$1,005
Nevro Corp.	14	$708
Abbott	8	$652
Averitas Pharma Inc.	5	$505
Saluda Medical Americas, Inc.	2	$367
SPR Therapeutics, Inc	2	$307
Si-bone, Inc.	1	$158
Wenzel Spine, Inc.	1	$154
Nalu Medical, Inc.	1	$150
Relievant Medsystems, Inc.	1	$132
Avanos Medical	1	$68
Globus Medical	2	$40
Pacira Pharmaceuticals Incorporated	1	$15
Vertex	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,150 in reported general payments places this provider in the 65th percentile of 57 interventional pain medicine providers in Louisiana.

See all interventional pain medicine providers in Louisiana →

Medicare billing

Part B allowed, 2024

$42,476

Medicare patients

153

Services billed

397

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lidocaine	34	$3,314
Pregabalin	136	$1,699
Tizanidine Hcl	103	$1,661
Gabapentin	156	$1,579
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	49	$1,305
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	60	$1,169
Methocarbamol	98	$951
Diclofenac Sodium	23	$554
Cyclobenzaprine Hcl	45	$479
Duloxetine Hcl	29	$343
Baclofen	11	$322
Celecoxib	25	$290
Oxycodone Hcl	11	$181
Tramadol Hcl	20	$98
Nortriptyline Hcl	11	$74

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in New Orleans

Maged GuirguisNew Orleans$565K
Suneil JollyKenner$107K
John CefaluShreveport$71K
Steve LeeSlidell$57K
William WhyteShreveport$39K
Paul HubbellMetairie$33K
Ken EhrhardtHammond$22K
Thomas BerryLacombe$21K
Randall BrewerShreveport$19K
Corey Ann ConnCovinton$18K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →